80 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
and our assessment of potential acquisition or in-licensing opportunities require substantial technical, financial and human resources, regardless … be enforced through civil whistleblower, or qui tam actions, as well as civil monetary penalty laws can impose criminal and civil penalties, assessment
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
or similar assessment, fine or penalty levied against it except as may be being contested in good faith and by appropriate proceedings. To the extent required
424B5
c6an0ykfyrkvo lq
29 Nov 23
Prospectus supplement for primary offering
5:05pm
424B5
cck8qzup
23 Jun 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
sj8lzpsx1ds
23 Jun 22
Other Events
4:04pm
424B5
sszc8x 1nqnu0vod29n1
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
0jrvg4u086w7 nre
1 Mar 22
Prospectus supplement for primary offering
5:12pm
8-K
EX-10.1
i4f5n
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm